Ann: MESOBLAST PROVIDES UPDATE ON CLINICAL PROGRA, page-3

re: Ann: MESOBLAST PROVIDES UPDATE ON CLINICA... Excellent update (both Crohns & GVHD) but unfortunately no impact on SP - like everyone feeling a little teased with the SP. Having said that, I continue to look forward to company updates and developments.

Also MSB's Management team (website) has been updated to include the two recent appointments being W Burns and J Symmonds. The one that I find intriguing is the appointment of J Symmonds (we already have Jenni Pilcher - Chief Financial Officer). This is what the MSB Site says about J Symmonds:

Jonathan R. Symonds - CBE, BA, FCA
Corporate Finance and Strategy

I would luv to know why a company (as small as MSB) needs someone of the Character and nature of J Symmonds ?? ....where as I can undertand his appointment as a non-executive Director of HSBC Holdings plc and Chairman of HSBC’s European subsidiary, HSBC Bank plcn .

Hopefully - we find out oneday.

Please DYOR.